Kisspeptin Administration Stimulates Reproductive Hormones but Does Not Affect Anxiety in Humans

Area of Science:

• Neuroendocrinology
• Reproductive Medicine
• Psychiatry

Background:

• Kisspeptin activates the reproductive system and is explored for treating reproductive and psychosexual disorders.
• Conflicting animal studies show varied effects of kisspeptin on anxiety, necessitating human investigation.

Purpose of the Study:

• To comprehensively investigate the effects of kisspeptin on anxiety in humans.
• To clarify kisspeptin's role in anxiety regulation for therapeutic development.

Main Methods:

• A double-blind, randomized, placebo-controlled, crossover study involving 95 participants.
• Intravenous kisspeptin-54 infusion was administered and compared to placebo.
• Anxiety, hormones (LH, cortisol), and physiological measures (heart rate, blood pressure) were assessed.

Main Results:

• Kisspeptin administration confirmed biological activity by increasing serum LH (P<0.001).
• No significant alteration in state anxiety was observed between kisspeptin and placebo (P=0.13).
• Kisspeptin did not significantly affect cortisol, blood pressure, or heart rate.

Conclusions:

• Kisspeptin administration does not appear to influence anxiety levels in humans.
• These findings are crucial for the development of kisspeptin-based therapeutics, particularly regarding anxiety.
• Further research may explore kisspeptin's nuanced effects in specific populations or conditions.